Patent Assignment
Reel/Frame 015331/0246
A Corrective Assignment to Remove a Incorrect Serial Number 10/226,922 on Reel 014559 Frame 0751
Recorded: 2004-05-17
Received: 2004-05-19
Pages: 22
Assignor
RIBOZYME PHARMACEUTICALS, INC.
Executed: 2003-04-16
Assignee
SIRNA THERAPEUTICS, INC.
2950 WILDERNESS PLACE, BOULDER, CO, 80301, UNITED STATES
Covered Property
(1)
RNA interference mediated inhibition of prostaglandin D2 receptor (PTGDR) and prostaglandin D2 synthetase (PTGDS) gene expression using short interfering RNA
Application:
10/226,992 →